Aaron Philip Mitchell

29PUBLICATIONS

90CO-AUTHORS

Regenerative medicine (incl. stem cells)Preventative health carePredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (29)

Sort by Publication Date:

|Jun 22, 2026

Timeliness of Prostate Cancer Treatment in Medicare Advantage and Traditional Medicare: More Similarities than Differences?

|Apr 01, 2026

When Priority Review No Longer Prioritizes.

Maryam Mooghali, Aaron P Mitchell

|Feb 03, 2026

Adoption and Regional Variation of Prostate-Specific Membrane Antigen Positron Emission Tomography in the United States.

Michael S Leapman, Jessica B Long, Sarah Westvold

|Dec 02, 2025

What Is the Cost Impact of Second Opinions in Oncology? A Retrospective Review.

Benjamin R Roman, Allison Lipitz-Snyderman, Susan Chimonas

|Nov 07, 2025

Pricing Trends and Overlapping Indications of Checkpoint Inhibitors for Cancer Treatment.

Jeddeo M Paul, Aaron P Mitchell, Aaron S Kesselheim

|Nov 05, 2025

Provider billing margin and cancer treatment selection: population based cohort study.

Aaron P Mitchell, Stacie B Dusetzina, Akriti Mishra Meza

Pageof 5

Frequent Collaborators

Akriti Mishra Meza

Sonia Persaud

Nirjhar Chakraborty

Sara Tabatabai

Michael J Morris

Bobby Daly

Mithat Gönen

Niti U Trivedi

Peter B Bach

Allison Lipitz-Snyderman

Frequent Collaborators

Akriti Mishra Meza

Sonia Persaud

Nirjhar Chakraborty

Sara Tabatabai